SLC16A12 Antisense RNA 1 (SLC16A12-AS1)

SLC16A12 Antisense RNA 1 (SLC16A12-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the SLC16A12 locus, located on human chromosome 10. It is classified as an antisense RNA, meaning it is complementary to the mRNA transcript of the SLC16A12 gene, which encodes a solute carrier transport protein (not to be confused with the antisense RNA itself)[3]. There is no known protein product, and its biological function remains largely uncharacterized. Unlike well-studied antisense RNAs such as SLC16A1-AS1, which have documented roles in cancer biology and gene regulation[2][4], SLC16A12-AS1 has not been directly implicated in disease pathogenesis, cellular signaling, or as a therapeutic target. Public gene databases (GeneCards, NCBI) list this as a validated genetic locus but do not attribute specific molecular or disease roles, protein interactions, or drug targeting[3]. Further research is required to determine whether SLC16A12-AS1 has functional or clinical relevance similar to better-characterized antisense RNAs from the SLC family. Note on potential confusion: SLC16A12-AS1 (SLC16A12 Antisense RNA 1) is distinct from SLC16A1-AS1, which is an extensively studied lncRNA with established roles in cancer and molecular signaling[2][4]. If your interest is in cancer biology or therapeutic targeting, consider verifying the intended target for specificity, as SLC16A1-AS1 is more prominent in the literature than SLC16A12-AS1.

Other names

SLC16A12-AS1SLC16A12 Antisense RNA 1lncSLC16A12-AS1